Biocon executive among 5 detained in ‘corruption’ case | India News

Advertisement

[ad_1]

NEW DELHI: The CCR arrested three people on Tuesday including L Praveen Kumar, Associate Vice President and Head of National Regulatory Affairs of Bengaluru Biocon Biologics Limiteda company founded by Kiran Mazumdar-Shaw, as part of their investigations into the alleged link between a few pharmaceutical companies and officials of the Central pharmaceutical standards control organization (CDSCO).
Guljit Sethi of Bioinnovat Research Services, Delhi and Animesh Kumar, Assistant Drug Inspector at CDSCO were also among those arrested.
The agency had on Monday apprehended co-controller of drugs, S Eswara Reddy, and Dinesh Dua, director of Synergy Network India Private Limited. The two were also formally arrested on Tuesday, bringing the total number of arrests in the alleged corruption case to five.
The FIR filed by CBI in the alleged bribery case involving pharmaceutical companies and drug control officials says that Central Drugs Standard Control Organization (CDSCO) official S Eswara Reddy, who handled case processing related to drug and vaccine approval applications by various pharmaceutical companies, had received three filings from Biocon Biologics Limited, Bengaluru, including one related to the waiver of phase III clinical trials of “insulin aspart” injection. TOI reviewed the FIR.
Mazumdar-Shaw had reacted to the allegation that L Praveen Kumar of Biocon Biologics and other defendants used bribes to obtain permission for a insulin injectionand dismissed the charges.
The FIR claims that Sethi, director of Delhi-based Bioinnovat Research Services, had handled government regulatory work related to Biocon Biologics and acted as a conduit on behalf of various pharmaceutical companies. According to the FIR, she had arranged to hand over a huge amount of bribes, through co-defendant Dinesh Dua and others, to senior CDSCO officers on different occasions for dealing favorably with the files. . The CBI alleged that Reddy at the Expert Committee on the Subject (SEC) meeting on May 18 this year supported waiving phase III clinical trials for the Insulin Aspart Injection. He also accuses the manager of manipulating the minutes of the meeting by changing the word “data” to “protocol” in the recommendations, thereby causing a substantial “undue gain” to M/s Biocon Biologics.
According to the FIR, Sethi allegedly conspired with Praveen Kumar and other senior Biocon Biologics executives to pay a bribe of Rs 9 lakh to Reddy for handling records related to the business promoted by Mazumdar-Shaw and for favorably recommending the Insulin Aspart Injection filing at the SEC meeting.
Sethi and Reddy reportedly agreed to include Biocon Biologics’ third filing at the June 15 SEC meeting. a favorable decision at the SEC meeting, the agency said.
Later in the day, CBI said Praveen Kumar informed Sethi that the case was approved at that meeting.
At the June 15 meeting, Reddy reportedly provided his new official residence at Chanakyapuri in Delhi to Dua to meet him there at the end of the week. Sethi then ordered Dua to hand over part of the agreed bribe amount (Rs 4 lakh out of the agreed Rs 9 lakh) on behalf of the company to Reddy. CBI received reports that Dua would meet Reddy at his residence on June 20 to deliver the bribe collected from Sethi and set a trap, which resulted in the arrests. Searches were carried out at several locations, resulting in the recovery of incriminating documents and articles, the agency said.



[ad_2]

You Can Read Also

World News

Advertisement

malek

Leave a Reply

Your email address will not be published.